The seventh myth of lipoprotein(a): Where and how is it assembled?

Current Opinion in Lipidology

Volumn 10, Issue 3, 1999, Pages 275-283

  Dieplinger, Hans ^b   Utermann, Gerd ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B100; BREFELDIN A; CYSTEINE; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; NEOMYCIN;

ATHEROGENESIS; CELL LINE; COVALENT BOND; DISULFIDE BOND; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; KINETICS; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; LIPOPROTEIN SYNTHESIS; LIVER CELL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN STRUCTURE; REVIEW; TRANSGENIC MOUSE;

ANIMALS; HUMANS; LIPOPROTEIN(A); PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA PROCESSING, POST-TRANSCRIPTIONAL;

EID: 0032816599     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199906000-00010     Document Type: Review

References (82)

1. 1 Utermann, G. 1993. Lipoprotein(a). In The metabolic basis of inherited disease. Scriver Ch R,Beaudet AL, Sly WS (editors). McGraw Hill Inc., New York. pp. 1887-1912.
2. 2 Dieplinger H, Kronenberg F. Genetics and metabolism of lipoprotein(a) and their clinical implications (Part 1). Wien. Klin. Wochenschr. 1999; 111:5-20.
3. 3 Kraft HG, Sandholzer C, Menzel HJ, Utermann G. Apolipoprotein(a) alleles determine lipoprotein(a) particle density and concentration in plasma. Arterioscler Thromb 1992; 12:302-306.
4. 4 McLean JW. Tomlinson JE, Kuang W-J, Eaton DL, Chen EY, Fless GM, Scanu AM, Lawn RM. cDNA sequence of human apolipoprotein (a) is homologeous to plasminogen. Nature 1987; 300:132-137.
5. 5 Haibach C, Kraft HG, Kochl S, Abe A, Utermann G. The number of kringle IV repeats 3-10 is invariable in the human apo(a) gene. Gene 1998; 208:253-258.
6. 6 Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, Seitz C. Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest 1987; 80:458-465.
7. 7 Kronenberg F, Utermann G, Dieplinger H. Lipoprotein(a) in renal disease. Am J Kidney Dis. 1996; 27:1-25.
8. 8 Utermann G. Genetic architecture and evolution of the lipoprotein(a) trait. Curr. Opin. Lipidol. 1999; 10:133-141.
9. 9 Cohen JC, Chiesa G, Hobbs HH. Sequence polymorphisms in the apolipoprotein(a) gene. J. Clin. Invest. 1993; 91:1630-1636.
10. 10 Krempler F, Kostner GM, Bolzano K, Sandhofer F. Turnover of lipoprotein(a) in man. J Clin Invest 1980; 65:1483-1490.
11. 11 Rader DJ, Cain W, Ikewaki K.Talley G, Zech LA, Usher D, Brewer HBJr. The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate. J Clin Invest 1994; 93:2758-2763.
12. 12 Rader DJ, Cain W, Zech LA, Usher D, Brewer HB Jr. Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein(a) isoform is determined by the rate of lipoprotein(a) production. J Clin Invest 1993; 91:443-447.
13. 13 Kraft HG, Menzel HJ, Hoppichler F, Vogel W, Utermann G. Changes of genetic apolipoprotein phenotypes caused by liver transplantations. Implications for apolipoprotein synthesis. J Clin Invest 1989; 83:137-142.
14. 14 Ramharack R, Spahr MA, Kreick JS, Sekerke CS. Expression of apolipoprotein[a] and plasminogen mRNAs in cynomolgus monkey liver and extrahepatic tissues. J Lipid Res 1996; :2029-2040.
15. 15 Tomfinson JE, McLean JW, Lawn RM. Rhesus monkey apolipoprotein(a). Sequence, evolution, and sites of synthesis. J Biol Chem 1989; 264:5957-5965.
16. 16 Koschinsky ML, Tomlinson JE, Zioncheck TF, Schwartz K, Eaton DL, Lawn RM. Apolipoprotein(a); Expression and characterization of a recombinant form of the protein in mammalian cells. Biochemistry 1991; 30:5044-5051.
17. 17 Vu H, Cianflone K, Zhang Z, Kalant D, Sniderman AD. Characterization and modulation of LP(a) in human hepatoma HEPG2 cells. Biochim Biophys Acta 1997; 1349:97-108.
18. 18 Lobentanz EM, Dieplinger H. Biogenesis of lipoprotein(a) in human and animal hepatocytes. Electrophoresis 1997; 18;2677-2681.
19. 19 Chiesa G, Hobbs HH, Koschinsky ML, Lawn RM, Maika SD, Hammer RE. Reconstitution of lipoprotein(a) by infusion of human low density lipoprotein into transgenic mice expressing human apolipoprotein(a). J Biol Chem 1992; 267:24369-24374.
20. 20 White AL. Biogenesis of Lp(a) in transgenic mouse hepatocytes. Clin Genet 1997; 52:326-337.
21. 21 Zysow BR., Kauser K, Lawn RM, Rubanyi GM. Effects of estrus cycle, ovariectomy, and treatment with estrogen, tamoxifen, and progesterone on apolipoprotein(a) gene expression in transgenic mice. Arterioscler Thromb Vasc Biol 1997; 17:1741-1745.
22. 22 Hixson JE, Jett C, Birnbaum S. Identification of promoter sequences in the 5′ untranslated region of the baboon apolipoprotein[a] gene. J Lipid Res 1996; 37:2324-2331.
23. 23 Wade DP, Lindahl E, Lawn RM. Apolipoprofein(a) gene transcription is regulated by liver-enriched trans-acting factor hepatocyte nuclear factor 1α. J Biol Chem 1994; 269:19757-19765.
24. 24 Frazer KA., Narla G, Zhang JL, Rubin EM. The apolipoprotein(a) gene is regulated by sex hormones and acute-phase inducers in YAC transgenic mice. Nature Genet 1995; 9:424-431.
25. 25 Hixson JE, Britten ML, Manis GS, Rainwater DL. Apolipoprotein (a) glycoprotein isoforms result from size differences in apo(a) mRNA in baboons. J Biol Chem 1998; 264:6013-6016.
26. 26 Azrolan N, Gavish D, Breslow JL. Plasma lipoprotein(a) concentration is controlled by apolipoprotein(a) (Apo(a)) protein size and the abundance of hepatic Apo(a) mRNA in a cynomolgus monkey model. J Biol Chem 1991; 266:13866-13872.
27. 27 Ehrlich KC, Ehrlich M. Highly repeated sites in the apolipoprotein(a) gene recognized by methylated DNA-binding protein, a sequence-specific DNA-binding protein. Mol Cell Biol 1990; 10:4957-4960.
28. 28 Suzuki K, Kuriyama M, Saito T, Ichinose A. Plasma lipoprotein(a) levels and expression of the apolipoproitein(a) gene are dependent on the nucleotide polymorphisms in its 5′-flanking region. J Clin Invest 1997; 99:1361-1366.
29. 29 Zysow BR, Lindahl GE, Wade DP, Knight BL, Lawn RM. C/T polymorphism in the 5′ untranslated region of the apolipoprotein(a) gene introduces an upstream ATG and reduces in vitro translation. Arterioscler Thromb 1995;15:58-64.
30. 30 White AL, Lanford RE. Biosynthesis and metabolism of lipoprotein(a). Curr Opin Lipidol 1995; 6:75-80.
31. 31 Brunner C, Lobentanz EM, Petho-Schramm A, Ernst A, Kang C, Dieplinger H, Muller HJ, Utermann G. The number of identical kringle IV repeats in apolipoprotein(a) affects its processing and secretion by HepG2 cells. J Biol Chem. 1996; 271:32403-32410.
32. 32 Lobentanz EM., Krasznai K, Gruber A, Brunner C, Muller HJ, Sattler J, et al. Intracellular metabolism of human apolipoprotein(a) in stably transfected Hep G2 cells. Biochemistry 1998; 37:5417-5425. Extensive in-vitro study in stably transfected HepG2 cells. The authors investigated by metabolic labelling experiments an apo(a)-isoform intracellular retention of apo(a) that regulates apo(a) secretion. They further convincingly demonstrated by several means of blocking the secretory pathway that no intracellular assembly occurs, at least in this cell line.
33. 33 White AL, Hixson JE, Rainwater DL, Lanford RE. Molecular basis for 'null' lipoprotein(a) phenotypes and the influence of apolipoprotein(a) size on plasma lipoprotein(a) level in the baboon. J Biol Chem 1994; 269:9060-9066.
34. 34 Frank S, Krasznai K, Durovic S, Lobentanz E-M, Dieplinger H, Wagner E, et al. High-level expression of various apolipoprotein(a) isoforms by 'transferrinfection': The role of kringle IV sequences in the extracellular association with low-density lipoprotein. Biochemistry 1994; 33:12329-12339.
35. 35 Bonen DK, Nassir F, Hausman AM, Davidson NO. Inhibition of N-linked glycosylation results in retention of intracellular apo[a] in hepatoma cells, although nonglycosylated and immature forms of apolipoprotein[a] are competent to associate with apolipoprotein B-100 in vitro. J Lipid Res 1998; 39:1629-1640.
36. 36 White AL, Guerra B, Lanford RE. Influence of allelic variation on apolipoprotein(a) folding in the endoplasmic reticulum. J Biol Chem 1997; 272:5048-5055.
37. 37 Nassir F, Bonen DK, Davidson NO. Apolipoprotein(a) synthesis and secretion from hepatoma cells is coupled to triglyceride synthesis and secretion. J Biol Chem 1998; 273:17793-17800.
38. 38 Furukawa S, Sakat N, Ginsberg HN, Dixon JL. Studies of the sites of intracellular degradation of apolipoprotein B in Hep G2 cells. J Biol Chem 1992; 267:22630-22638.
39. 39 White AL, Guerra B, Wang J, Lanford RE. Presecretory degradation of apolipoprotein[a] is mediated by the proteasome pathway. J Lipid Res 1999; 40:275-286. First report of intracellular degradation of apo(a) by the ubiquitin-proteasome pathway to regulate apo(a) secretion in primary baboon hepatocytes.
40. 40 Wang J, White AL. 6-Aminohexanoic acid as a chemical chaperone for apolipoprotein(a). J Biol Chem 1999; 274:12883-12889.
41. 41 Bonifacino JS, Weissman AM. Ubiquitin and the control of protein fate in the secretory and endocytic pathways. Annu Rev Cell Dev Biol 1998; 14:19-57. Brilliant overview of intracellular degradation of secretory proteins by the proteasomal machinery.
42. 42 Raposo G, van Santen HM, Leijendekker R, Geuze HJ, Ploegh HL. Misfolded major histocompatibility complex class 1 molecules accumulate in an expanded ER-Golgi intermediate compartment. J Cell Biol 1995; 131:1403-1419.
43. 43 Brunner CH, Kraft HG, Utermann G, Müller HJ. Cys4057 of apolipoprotein(a) is essential for lipoprotein(a) assembly. Proc Natl Acad Sci USA 1993; 90:11643-11647.
44. 44 Koschinsky ML, Côté GP, Gabel B, Van der Hoek YY. Identification of the cysteine residue in apolipoprotein(a) that mediates extracellular coupling with apolipoprotein B-100. J Biol Chem 1993; 268:19819-19825.
45. 45 Ernst A, Brunner C, Pethö-Schramm A, Helmhold M, Kraft H-G, Utermann G, et al. Assembly and lysine binding of recombinant lipoprotein(a). In: Atherosclerosis X. Proceedings of the 10th International Symposium on Atherosclerosis, Montreal, October 9-14, 1994. Woodford FP, Davignon J, Sniderman A (editors). Amsterdam-Lausaunne-New York-Oxford-Shannon-Tokyo: Elsevier, 1995. pp. 879-883.
46. 46 Wilkinson J, Munro LH, Higgins JA. Apolipoprotein[a] is not associated with apolipoprotein B in human liver. J Lipid Res 1994; 35:1896-1901.
47. 47 White AL, Lanford RE. Cell surface assembly of lipoprotein(a) in primary cultures of baboon hepatocytes. J Biol Chem 1994; 269:28716-28723.
48. 48 Lanford RE, Estlack L, White A. Neomycin inhibits secretion of apolipoprotein[a] by increasing retention on the hepatocyte cell surface. J Lipid Res 1996; 37:2055-2064.
49. 49 Gurakar A, Hoeg JM, Kostner GM, Papadopoulos NM, Brewer BH Jr. Levels of lipoprotein Lp (a) decline with neomycin and niacin treatment. Atherosclerosis 1985; 57:293-301.
50. 50 Edelstein C, Davidson NO, Scanu AM. Oleate stimulates the formation of triglyceride-rich particles containing APOB100-APO(a) in long-term primary cultures of human hepatocytes. Chem Phys Lipids 1994; 67-68:135-143.
51. 51 Bonen DK, Hausman ML, Hadjiagapiou C, Skarosi SF, Davidson NO. Expression of a recombinant apolipoprotein(a) in HepG2 cells. Evidence for intracellular assembly of lipoprotein(a). J Biol Chem 1997; 272:5659-5667. Expression of a recombinant apo(a) lacking the repetitive kringle 4 domains was demonstrated to be able to intracellularly assemble Lp(a) in stably transfected HepG2 cells. The physiological significance of this finding remains to be clarified since an Lp(a) particle of such a small size does not exist in humans.
52. 52 Trieu VN, McConathy WJ. The binding of animal low-density lipoproteins to human apolipoprotein(a). Biochem J 1995; 309:899-904.
53. 53 Morrisett J, Gaubatz J, Nava M, Guyton J, Hoffmann A, Opekum A, Hachey D. Metabolism of apo[a] and apoB-100 in human lipoprotein[a] [abstract]. Sec. Intern. Conference on Lipoprotein(a) 1992; 71.
54. 54 Su W, Campos H, Judge H, Walsh BW, Sacks FM. Metabolism of Apo(a) and ApoB100 of lipoprotein(a) in women: effect of postmenopausal estrogen replacement. J Clin Endocrinol Metab 1998; 83:3267-3276. First in-vivo kinetic study of Lp(a) in humans (somehow cryptically hidden in the title) using the stable isotope technology. By this method, the authors were able to separately investigate the kinetics of the apo(a) and apoB-100 moieties of Lp(a). They found an almost identical synthesis rate for both proteins, which is compatible with intracellular Lp(a) assembly. Since these results definitely exclude the possibility of extracellular assembly of newly synthesized apo(a) with circulating LDL, they are in strict opposilion to the data obtained in most cell culture studies.
55. 55 White AL, Rainwater DL, Lanford RE. Intracellular maturation of apolipoprotein[a] and assembly of lipoprotein[a] in primary baboon hepatocytes. J Lipid Res 1993; 34:509-517.
56. 56 Dashti N, Alaupovic P, Knight-Gibson C, Koren E. Identification and partial characterization of discrete Apolipoprotein B containing lipoprotein particles produced by human hepatoma cell line HepG2. Biochemistry 1987; 26:4837-4846.
57. 57 Bouma ME, Pessah M, Renaud G, Amit N, Catala D, Infante R. Synthesis and secretion of lipoproteins by human hepatocytes in culture. In. Vitro Cell Dev Biol 1998; 24:85-90.
58. 58 Salhanick AI., Schwartz SI, Amatruda JM. Insulin inhibits apolipoprotein B secretion in isolated human hepatocytes. Metabolism 1991; 40:275-279.
59. 59 Millar JS, Packard CJ. Heterogeneity of apolipoprotein B-100-containing lipoproteins: what we have learnt from kinetic studies. Curr Opin Lipidol 1998; 9:197-202.
60. 60 Sommer A, Gorges R, Kostner GM, Paltauf F, Hermetter A. Sulfhydryl-selective fluorescence labeling of lipoprotein(a) reveals evidence for one single disulfide linkage between apoproteins(a) and B-100. Biochem 1991; 30:11245-11249.
61. 61 McCormick SP, Ng JK, Taylor S, Flynn LM, Hammer RE, Young SG. Mutagenesis of the human apolipoprotein B gene in a yeast artificial chromosome reveals the site of attachment for apolipoprotein(a). Proc Natl Acad Sci USA 1995; 92:10147-10151.
62. 62 Guevara J, Spurlino J, Jan AY, Yang CY, Tulinsky A, Prasad BVV, Gaubatz JW, Morrisett JD. Proposed mechanisms for binding of apo(a) kringle type 9 to apo-B-100 in human lipoprotein(a). Biophys J 1993; 64/3:686-700.
63. 63 Guevara JJr, Valentinova NV, GarciaO, Gotto AM, Yang CY, Legal S, et al. Interaction of apolipoprotein[a] with apolipoproteinB-100 Cys3734 region in lipoprotein[a] is confirmed immunochemically. J Protein Chem 1996; 15:17-25.
64. 64 Coleman RD, Kim TW, Gotto AM, Yang CY. Determination of cysteine on low-density lipoproteins using the fluorescent probe, 5-iodoacetamidofluoresceine. Biochim Biophys Acta 1990; 1037:129-132.
65. 65 Koschinsky ML, Marcovina SM, May LF, Gabel BR. Analysis of the mechanism of lipoprotein(a) assembly. Clin Genet 1997; 52:338-346.
66. 66 McCormick SPA, Linton MF, Hobbs HH, Taylor S, Curtiss LK, Young SG. Expression of human apolipoprotein B90 in transgenic mice. Demonstration that apolipoprotein B90 lacks the structural requirements to form lipoprotein(a). J Biol Chem 1994; 269:24284-24289.
67. 67 Averna M, Marcovina SM, Noto D, Cole TG, Krul ES, Schonfeld G. Familial hypobetalipoproteinemia is not associated with low levels of lipoprotein(a)-Arterioscler. Thromb Vasc Biol 1995; 15:2165-2175.
68. 68 Gabel B, Yao Z, McLeod RS, Young SG, Koschinsky ML. Carboxyl-terminal truncation of apolipoproteinB-100 inhibits lipoprotein(a) particle formation. FEBS Lett 1994; 350:77-81.
69. 69 Rouy D, Duverger N, Lin SD, Emmanuel F, Houdebine LM, Denefle P, et al. Apolipoprotein(a) yeast artificial chromosome transgenic rabbits. Lipoprotein(a) assembly with human and rabbit apolipoprotein B J Biol Chem 1998; 273:1247-1251.
70. 70 Fan J, Araki M, Wu L, Challah M, Shimoyamada H, Lawn RM, et al. Assembly of Lipoprotein (a) in Transgenic Rabbits Expressing Human Apolipoprotein (a). Biochem. Biophys Res Commun 1999; 255:639-644.
71. 71 Frank S, Durovic S, Kostner GM. The assembly of lipoprotein Lp(a). Eur J Clin Invest 1996; 26:109-114.
72. 72 McCormick SP; Nielsen LB. Expression of large genomic clones in transgenic mice: new insights into apolipoprotein B structure, function and regulation. Curr Opin Lipidol 1998; 9:103-111. Excellent overview of the author's work including the molecular dissection of structures on apoB-100 involved in the complex assembly process of Lp(a).
73. 73. Frank S, Durovic S, Kostner GM. Structural requirements of apo-a for the lipoprotein-a assembly. Biochem J 1994; 304:27-30.
74. 74 Trieu VN; McConathy WJ. A two-step model for lipoprotein(a) formation. J Biol Chem 1995; 270:15471-15474.
75. 75 Ernst A, Helmhold M, Brunner C, Pethö-Schramm A, Armstrong VW, Müller H-J. Identification of two functionally distinct lysine-binding sites in kringle 37 and in kringles 32-36 of human apolipoprotein(a). J Biol Chem 1995; 270:6227-6234.
76. 76 Gabel BR, May LF, Marcovina SM, Koschinsky ML. Lipoprotein(a) assembly. Quantitative assessment of the role of apo(a) kringle IV types 2-10 in particle formation. Arterioscler Thromb Vasc Biol 1996; 16:1559-1567.
77. 77 Gabel BR, Koschinsky ML. Sequences within apolipoprotein(a) kringle IV types 6-8 bind directly to low-density lipoprotein and mediate noncovalent association of apolipoprotein(a) with apolipoprotein B-100. Biochemistry 1998; 37:7892-7898.
78. 78 Boonmark NW, Lawn RM. The lysine-binding function of Lp(a). Clin Genet 1997; 52:355-360.
79. 79 McCormick SP, Ng JK, Cham CM, Taylor S, Marcovina SM, Segrest JP, et al. Transgenic mice expressing human ApoB95 and ApoB97. Evidence that sequences within the carboxyl-terminal portion of human apoB100 are important for the assembly of lipoprotein. J Biol Chem 1997; 272:23616-23622. Mutant YAC coding for truncated human apolipoprotein B were used in this study to express these forms in transgenic mice. The results revealed that sequences C-terminal to apo B95 are necessary for efficient Lp(a) assembly, most likely via lysine binding sites on kringle 4 types 5 to 8 suggesting an opposite (C-terminal to N-terminal) orientation of the two involved proteins.
80. 3500->Gln). A study of the assembly of recombinant apolipoprotein (a) with mutant low density lipoproteins. J Biol Chem 1994; 269:30320-30325.
81. 81 Steyrer E, Durovic S, Frank S, Glessauf W, Burger A, Dieplinger H, et al. The role of lecithin: cholesterol acyltransferase for lipoprotein (a) assembly. Structural integrity of low density lipoproteins is a prerequisite for Lp(a) formation in human plasma. J Clin Invest 1994; 94:2330-2340.
82. 82 Menzel H -J, Dieplinger H, Lackner C, Hoppichler F, Lloyd JK, Muller DR, et al. Abetalipoproteinemia with an ApoB-100-lipoprotein(a) glycoprotein complex in plasma. Indication for an assembly defect. J Biol Chem 1990; 265:981-986.